Basel 3.1 Delay Isn’t Relief – It’s a Compressed Risk Window

May 19, 2026

The Reality Most Banks Are Underestimating

The UK’s decision to delay Basel 3.1 to 2027, with FRTB IMA following in 2028, is being treated by many as breathing space.

It isn’t.

It creates a compressed hybrid transition period, with a binding dual‑regime operating model in 2027 and material approval risk extending into 2028, where complexity, capital uncertainty, and regulatory scrutiny all increase at the same time.

Banks will be forced to operate across:

This is not a sequencing exercise. It is a live, high-risk operating model shift, where legacy frameworks, new capital rules, and approval readiness all overlap under real capital pressure.

Most organisations are not set up to run this well.

Where Programmes Will Break

Across Basel and FRTB programmes, failure is rarely technical. It is structural.

The same patterns are already emerging:

This is exactly where programmes start to drift — and where recovery becomes expensive.

What Needs to Be Done Differently

Banks that navigate this successfully will not treat Basel 3.1 as a regulatory project.

They will treat it as a capital, business, and operating model transformation.

The focus shifts from compliance to control, alignment, and execution.

1. Run a Controlled Dual-Regime Model — Not Parallel Chaos

You need a single, governed structure that:

If you cannot explain capital movements clearly, you cannot control them.

2. Treat FRTB-SA as a Strategic Constraint

FRTB-SA will define capital outcomes in 2027 and influence supervisory expectations beyond that.

That means:

If SA is wrong, everything built on top of it fails.

3. Build IMA for Approval — Not Just Implementation

Most IMA programmes focus on passing tests. That’s not enough.

Approval depends on:

This requires early PRA engagement and disciplined execution, not a late-stage submission push.

4. Reposition SA-CCR as a Capital Engine

SA-CCR is now embedded across:

It is not optional. It is binding — either directly or via downstream constraints.

If SA‑CCR is not actively managed, capital efficiency erodes quickly.

Leading banks are:

If SA-CCR is not actively managed, capital efficiency erodes quickly.

5. Unify Capital, Risk, and Business Steering

Fragmentation kills control.

You need:

Capital must be visible, attributable, and actionable.

6. Engage the PRA Early — and Properly

Regulators are not just assessing models. They are assessing control, credibility, and consistency.

That means:

Late engagement is one of the fastest ways to delay approval.

The Commercial Reality

Most Basel 3.1 programmes will not fail outright.

They will drift:

Capital outcomes become volatile

Approval timelines slip

Confidence declines internally and with regulators

And by the time intervention happens, the programme is already under pressure.

Where Brickendon Comes In

Brickendon is brought in when:

We don’t advise from the sidelines.

We:

No leveraged teams.
No separation between oversight and execution.

Just control, clarity, and delivery under pressure.

Bottom Line

The Basel 3.1 delay has not reduced risk. It has concentrated it.

The question is not whether your programme is ready.

It is whether:

  • You can control capital across regimes
  • You can meet regulatory expectations with confidence
  • And you can deliver under sustained pressure

If not, the programme is already at risk.

And if it cannot fail, waiting is not a strategy.

[email protected]